Imunon SG&A Expense (TTM) Trends | YCharts

Imunon, Inc. (IMNN)

1.58 +0.02 (+1.28%) USD | NASDAQ | Sep 04, 16:00

1.57 -0.01 (-0.63%) After-Hours: 20:00

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for IMNN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (TTM) Chart

Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.

Date	Value
June 30, 2026	6.645M
March 31, 2026	6.859M
December 31, 2025	6.87M
September 30, 2025	7.011M
June 30, 2025	7.103M
March 31, 2025	7.756M
December 31, 2024	7.493M
September 30, 2024	7.994M
June 30, 2024	8.250M
March 31, 2024	8.396M
December 31, 2023	9.743M
September 30, 2023	11.38M
June 30, 2023	13.34M
March 31, 2023	13.88M
December 31, 2022	13.69M
September 30, 2022	12.27M
June 30, 2022	11.10M
March 31, 2022	10.82M
December 31, 2021	10.89M
September 30, 2021	10.37M
June 30, 2021	9.441M
March 31, 2021	8.740M
December 31, 2020	7.642M
September 30, 2020	7.340M
June 30, 2020	7.386M

Date	Value
March 31, 2020	7.621M
December 31, 2019	8.000M
September 30, 2019	8.725M
June 30, 2019	8.846M
March 31, 2019	10.25M
December 31, 2018	9.700M
September 30, 2018	8.766M
June 30, 2018	7.980M
March 31, 2018	6.087M
December 31, 2017	5.890M
September 30, 2017	5.930M
June 30, 2017	6.252M
March 31, 2017	6.132M
December 31, 2016	6.527M
September 30, 2016	6.258M
June 30, 2016	6.245M
March 31, 2016	6.518M
December 31, 2015	6.457M
September 30, 2015	7.165M
June 30, 2015	7.725M
March 31, 2015	8.228M
December 31, 2014	8.860M
September 30, 2014	8.302M
June 30, 2014	7.647M
March 31, 2014	7.292M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks

Start Trial

Phio Pharmaceuticals Corp.	4.941M
Agenus, Inc.	38.48M
Amgen, Inc.	7.019B
Anika Therapeutics, Inc.	52.67M
BioCryst Pharmaceuticals, Inc.	328.11M